[1]郝利霞.拉贝洛尔联合短效硝苯地平治疗早发型子痫前期疗效观察[J].新乡医学院学报,2020,37(5):444-447.[doi:10.7683/xxyxyxb.2020.05.011]
 HAO Lixia.Effect of labetalol combined with short-acting nifedipine in the treatment of early-onset pre-eclampsia[J].Journal of Xinxiang Medical University,2020,37(5):444-447.[doi:10.7683/xxyxyxb.2020.05.011]
点击复制

拉贝洛尔联合短效硝苯地平治疗早发型子痫前期疗效观察
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
37
期数:
2020年5
页码:
444-447
栏目:
临床研究
出版日期:
2020-05-05

文章信息/Info

Title:
Effect of labetalol combined with short-acting nifedipine in the treatment of early-onset pre-eclampsia
作者:
郝利霞
(新乡市妇幼保健院产三科,河南 新乡 453003)
Author(s):
HAO Lixia
(Department of Obstetrics,Xinxiang Maternal and Child Health Hospital,Xinxiang 453003,Henan Province,China)
关键词:
早发型子痫前期拉贝洛尔硝苯地平血压
Keywords:
early-onset pre-eclampsialabetalolnifedipineblood pressure
分类号:
R714.24+5
DOI:
10.7683/xxyxyxb.2020.05.011
文献标志码:
A
摘要:
目的 探讨拉贝洛尔联合短效硝苯地平治疗早发型子痫前期的临床效果。方法 选择2015年1月至2018年12月于新乡市妇幼保健院治疗并分娩的100例早发型子痫前期患者为研究对象,根据治疗方法将患者分为观察组和对照组,每组50例。2组患者入院后均给予饮食营养摄入控制、间断吸氧、血压监控、镇静、卧床休息等常规干预措施,在常规干预措施基础上,对照组患者给予拉贝洛尔治疗,观察组患者给予拉贝洛尔和短效硝苯地平联合治疗。对2组患者治疗前后收缩压(SBP)、舒张压(DBP)及血清白血病抑制因子(LIF)和Apelin水平进行比较,治疗7 d后评估2组患者临床疗效,并观察2组围生期母婴不良预后发生情况。结果 观察组和对照组患者治疗总有效率分别为98.0%(49/50)、82.0%(41/50),观察组患者治疗总有效率高于对照组(χ2=7.426,P<0.05)。2组患者治疗前日间和夜间SBP、DBP比较差异均无统计学意义(P>0.05),2组患者治疗后日间和夜间SBP、DBP均低于治疗前(P<0.05);治疗后,观察组患者日间和夜间SBP、DBP均低于对照组(P<0.05)。2组患者治疗前血清LIF、Apelin水平比较差异均无统计学意义(P>0.05);2组患者治疗后血清LIF水平高于治疗前,Apelin水平低于治疗前(P<0.05);治疗后,观察组患者血清LIF水平高于对照组,Apelin水平低于对照组(P<0.05)。观察组和对照组围生期母婴不良预后发生率分别为4.0%(2/50)、18.0%(9/50),观察组围生期母婴不良预后发生率低于对照组(χ2=5.602,P<0.05)。结论 拉贝洛尔联合短效硝苯地平可以有效降低早发型子痫前期患者血压,改善母婴预后。
Abstract:
Objective To investigate the clinical effect of labetalol combined with short-acting nifedipine in the treatment of early-onset pre-eclampsia.Methods A total of 100 patients with early onset pre-eclampsia who delivered in Xinxiang Maternal and Child Health Hospital from January 2015 to December 2018 were selected as the study objects,and the patients were divided into observation group and control group according to the treatment method,with 50 cases in each group.After admission,the patients in both groups were given routine intervention measures such as diet control,intermittent oxygen inhalation,blood pressure monitoring,sedation,bed rest and so on.On the basis of routine interventions,the patients in the control group were treated with labetalol,while the patients in the observation group were treated with labetalol and short-acting nifedipine.The systolic blood pressure (SBP),diastolic blood pressure (DBP),serum leukaemia inhibitory factor (LIF) and Apelin levels were compared between the two groups before and after treatment.The clinical effect of the patients in the two groups was evaluated at seven days after treatment.The incidence of adverse maternal and neonatal outcomes in the two groups was observed.Results The total effective rate in the observation group and the control group was 98.0%(49/50) and 82.0% (41/50),respectively.The total effective rate in the observation group was higher than that in the control group (χ2 =7.426,P<0.05)。There was no significant difference in SBP and DBP during daytime and nighttime between the two groups before and after treatment (P>0.05).The SBP and DBP during daytime and nighttime after treatment were lower than those before treatment in the two groups (P<0.05).There was no significant difference in the levels of serum LIF and Apelin between the two groups before treatment (P>0.05).The serum LIF level after treatment was higher than that before treatment,and the serum Apelin level after treatment was lower than that before treatment in the two groups (P<0.05).After treatment,the serum LIF level in the observation group was higher than that in the control group,and the serum Apelin level in the observation group was lower than that in the control group (P<0.05).The incidence of adverse maternal and neonatal outcomes in the observation group and the control group was 4.0% (2/50) and 18.0% (9/50),respectively.The incidence of adverse maternal and neonatal outcomes in the observation group was lower than that in the control group (χ2 =5.602,P<0.05).Conclusion Labetalol combined with short-acting nifedipine can effectively reduce blood pressure in patients with early-onset pre-eclampsia and improve maternal and infant prognosis.

参考文献/References:

[1]  MAGEE L A,PELS A,HELEWA M,et al.Diagnosis,evaluation,and management of the hypertensive disorders of pregnancy:executive summary[J].J Obstet Gynaecol Can,2014,36(7):575-576.
[2] GUO L,TSAI S Q,HARDISON N E,et al.Differentially expressed microRNAs and affected biological pathways revealed by modulated modularity clustering (MMC) analysis of human preeclamptic and IUGR placentas[J].Placenta,2013,34(7):599-605.
[3] 王洁.联合采用拉贝洛尔和硝苯地平治疗重度子痫前期患者的效果评价[J].临床医药文献杂志,2017,4(91):17955-17957.
[4] 中华医学会妇产科学分会妊娠期高血压疾病学组.妊娠期高血压疾病诊治指南:2015[J].中华妇产科杂志,2015,50(10):721-728.
[5] 马丽.硫酸镁在妊娠期高血压治疗中的应用价值[J].河南医学研究,2015,24(3):120-120.
[6] 刘金金,崔世红,韩笑,等.重度子痫前期患者甲状腺激素水平及母婴结局分析[J].新乡医学院学报,2019,36(5):459-463.
[7] 倪琰琰.早发型子痫前期临床特征的对比分析[D].上海:上海交通大学,2015.
[8] 王文霞.拉贝洛尔联合硝苯地平对重度子痫前期的治疗价值及意义评析[J].中国医药指南,2016,14(23):59-59.
[9] 阮琦,区淑珍.甲基多巴联合拉贝洛尔治疗妊娠高血压的疗效观察及其机制探讨[J].岭南心血管病杂志,2016,22(4):446-448.
[10] ZHENG Q,DAI K,CUI X,et al.Leukemia inhibitory factor promote trophoblast invasion via urokinase-type plasminogen activator receptor in preeclampsia[J].Biomed Pharmacother,2016,80:102-108.
[11] THAKUR V,THAKUR A,SAROSHE S.Comparison of effect of niledipine,labetalol and methyldopa in treatment of hypertension in pregnancy in a tertiary care government hospital[J].Int J Reprod Contracept Obstet Gynecol,2016,5(1):1-6.
[12] 冯小玲,王鹤,魏洪发.硫酸镁联合血压平颗粒治疗妊娠高血压患者的临床疗效及对血清LIF、Apelin、β-HCG的影响[J].河北医学,2018,24(11):1841-1845.
[13] 童玲,危先江,王川,等.硫酸镁联合阿司匹林对妊娠高血压患者的妊娠结局分析[J].中国地方病防治杂志,2017,32(4):472-474.
[14] MAYEUR S,WATTEZ J S,LUKASZEWSKI M A,et al,Apelin controls fetal and neonatal glucose homeostasis and is altered bymaternal undernutrition[J].Diabetes,2016,65(3):554-560.
[15] EBERL D,MAROUSEZ L ,HANSSENS S,et al.Elabela and Apelin actions in healthy and pathological pregnancies[J].Cytokine Growth Factor Rev,2019,46:45-53.
[16] 高芳,孙素芬,李志,等.药物三联法治疗妊娠高血压疗效及对血清LIF及Apelin水平的影响[J].现代中西医结合杂志,2016,25(29):3236-3238.

相似文献/References:

[1]王倩,杜丹丽.血清基质金属蛋白酶-3和胱抑素C水平对早发型子痫前期患者妊娠结局的预测价值[J].新乡医学院学报,2023,40(12):1121.[doi:10.7683/xxyxyxb.2023.12.004]
 WANG Qian,DU Danli.Relationship between serum matrix metalloproteinase-3 and cystatin C levels and pregnancy outcome in pregnant women with early-onset preeclampsia[J].Journal of Xinxiang Medical University,2023,40(5):1121.[doi:10.7683/xxyxyxb.2023.12.004]

更新日期/Last Update: 2020-05-05